Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Ofer Merimsky
41 years of experience
accreditations :
Clinic is certified :
| Israel | Turkey | Austria | |
| Oncological Check-up for Man | from $500 | from $500 | from $500 |
No hidden fees – just official clinic prices. Pay at the clinic for Oncological Check-up for Man upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Oncological Check-up for Man and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Oncological Check-up for Man journey.
Dr. Ofer Merimsky heads the National Center for bone and soft tissue sarcomas at Sourasky Medical Center. He is a primary specialist in Israel for lung cancer and sarcoma treatment. Dr. Merimsky serves as Deputy Director of the Oncology Institute. He also specializes in complex Whipple surgery for pancreatic cancer cases. He works at JCI-accredited Sourasky Medical Center, ranked among the world's best hospitals by Newsweek.
Dr. Nadir Arber heads the Integrated Cancer Prevention Center at Sourasky Medical Center. He specializes in the early diagnosis and treatment of gastrointestinal tumors. Dr. Arber has authored over 300 scientific papers on GI cancer research. He conducted research at the NewYork-Presbyterian Center in the United States.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.